Rifabutin for treating pulmonary tuberculosis Unchanged
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifabutin for Treating Pulmonary Tuberculosis Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged. Accessed 27 May 2023.
Rifabutin for treating pulmonary tuberculosis Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged. Accessed May 27, 2023.
Rifabutin for treating pulmonary tuberculosis Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged
Rifabutin for Treating Pulmonary Tuberculosis Unchanged [Internet]. In: Cochrane Abstracts. [cited 2023 May 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifabutin for treating pulmonary tuberculosis Unchanged
ID - 433920
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -